|
Procedure
|
Procedure Overview
|
Purpose
|
Preparation
|
Complications
(if any)
|
Alternative Test
|
|
Tetrofosmin Rest MPI
|
Measures the blood flow and function of the heart using radioactive isotope as tracer
|
To diagnose myocardial infarction, more commonly known as a heart attack
|
4 hours fasting, no caffeinated drinks
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Tetrofosmin Rest/Stress MPI
|
It measures the blood flow and function of the heart using a radioactive isotope, also known as a radiotracer
|
To diagnose and determine the site of myocardial infarction (heart attack). To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart)
|
3 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/
hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
Rest/
Pharmacological Stress Test
|
|
Tetrofosmin
Express MPI
|
It measures the blood flow and function of the heart by injecting a radioactive isotope to serve as tracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart)
|
2 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
Pharmacological Stress Test
|
|
Rest/Dipyridamole Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart); alternative to treadmill exercise; for patients on high betablocker dose
|
3 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Express Dipyridamole Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart)
|
2 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Rest/Dobutamine Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart); alternative to treadmill exercise for patients with asthma
|
3 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Express Dobutamine Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart)
|
2 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Rest/Adenosine Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart); alternative to treadmill exercise for patients with LBBB, patients with significant Arrhythmia and patients with psychiatric history
|
3 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Express Adenosine Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart)
|
3 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Tl-201 Stress for Viability MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To detect myocardial viability
|
4 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Tl-201 Dipyridamole Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart); alternative to treadmill exercise; for patients on high betablocker dose
|
4 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Tl-201 Dobutamine Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart); alternative to treadmill exercise for patients with asthma
|
4 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Tl-201 Adenosine Infusion MPI
|
It measures the blood flow and function of the heart. It involves injection of a radiotracer
|
To diagnose ischemic heart disease or Coronary Artery Disease (reduced blood supply to the heart); alternative to treadmill exercise for patients with LBBB, patients with significant Arrhythmia and patients with psychiatric history
|
4 hours fasting, no caffeinated drinks
|
Chest pain, palpitations, hypertension/ hypotension, dyspnea, headache, dizziness, abnormal rhythms, and heart attack during the stress phase of the procedure. Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Gated Bloodpool Rest Imaging
|
It uses radioisotope dye
|
Using radioisotope dye, the test shows how your blood pools in your heart during rest
|
2 hours fasting
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Gated Bloodpool Rest/Stress Imaging
|
It uses radioisotope dye
|
Uses radioisotope dye to show how your blood pools in your heart during rest, exercise, or both
|
3 hours fasting
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Cardiac Blood Flow Imaging
|
A cardiac blood pool scan is a non-invasive test that uses a mildly radioactive marker to observe how the left ventricle of your heart functions
|
It is used to determine how efficiently the left ventricle is working. The scan can detect aneurysms of the left ventricle, motion abnormalities caused by damage to the heart wall, cardiac shunts between the left and right ventricle, and coronary occlusive artery disease
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Myocardial Infarct Imaging
|
It involves injection of a radiotracer and scanning of the region of interest using a gamma camera
|
To detect myocardial damage when enzyme determination and ECG are questionable
|
2 hours fasting, light meal only
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Brain SPECT Imaging
|
Procedure involves injection of radiotracer and scanning of the brain using a gamma camera.
|
To examine transient ischemic attack, migraine, and tumors of the brain and to diagnose dementia
|
Potassium perchlorate should be administered before the study.
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Brain Imaging
|
Procedure involves injection of radiotracer and scanning of the brain using a gamma camera
|
To check whether the patient has brain abnormalities such as infarct, hematoma, enoplasm, abcess, or other lesion disturbing the normal brain barrier
|
Potassium perchlorate will be administered before the study.
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
RAI Uptake
|
This involves an oral intake of I-131 at a minimal dose. Thyroid uptake is measured after 2 and 24 hours
|
To examine thyroid function
|
1st day: fasting from 12 midnight. Stop thyroid medications for 2-4 weeks or as advised by attending physician
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Thyroid Bioassay
|
Procedure involves examination of thyroid with the use of thyroid uptake probe
|
Evaluates exposure of thyroid after handling radioactive Iodine
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Thyroid Imaging
|
It involves injection of a radiotracer and thyroid is scanned using gamma camera after 20 minutes
|
To examine the morphology and function of thyroid gland thyrotoxicosis, goiter, and assessment of nodular goiter
|
Stop thyroid medications for 2-4 weeks or as advised by attending physician
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Parathyroid Imaging
|
Radiotracer is injected and a series of images of the neck is taken 15-, 90- and 180 minutes from the time of injection
|
To check if the patient has Hyperparathyroidism; To examine a specific area of the adenoma or ectopic parathyroid gland
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
RAI Whole Body Imaging
|
Involves oral intake of radiotracer and scanning after 48 hours from the time of intake
|
To determine whether the thyroid tissue is functioning properly and check particular areas of metastatic sites
|
Stop thyroid medications for 2-4 weeks or as advised by attending physician
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
MIBG WB Imaging
|
The procedure involves injection of I-131 MIBG
|
To examine specific areas of neuroectodermal tissues; To check for benign and malignant, intraadrenal and extraadrenal, phaeochromocytomas, neuroblastomas, carcinoid tumors, medullary thyroid tumors, paragangliomas, chemocetomas and evaluate of norepinephrine receptors
|
One drop of saturated Potassium Iodide is given by mouth 3 times a day for a total of 5 days, beginning the day before the injection of radiopharmaceutical
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Liver & Spleen Imaging
|
It involves injection of a radiopharmaceutical tracer and scanning of the organ in question.
|
To diagnose hepatomegaly and abdominal masses. Preoperative evaluation of liver metastases in patient with known metastases; workup of patient with diffuse liver disease such as cirrhosis and hepatitis
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Liver SPECT Imaging
|
Procedure involves injection of a radiopharmaceutical tracer and scanning of the organ of interest
|
To check for any small liver lesions that could not be detected in planar imaging
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
G.I. Bleeding Imaging
|
It involves injection of Tc99m pertechnetate tagged RBC and scanning of the abdominal area for any specific bleeding site
|
To examine a particular site of active gastrointestinal bleeding
|
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Meckel's Diverticulum Imaging
|
It involves injection of Tc99m pertechnetate and a series of scanning afterwards
|
To check for any bleeding, diverticulitis, intestinal obstruction due to intussuception and volvulus
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Gastric Emptying Imaging
|
Procedure involves the administration of Tc99m Sulfur Colloid per orem and afterwards, scanning of region of interest for 2 hours
|
To check the reason behind a patient’s delayed gastric emptying (a disorder in which the stomach takes too long to empty its contents) and identify gastric emptying rate
|
6 hours fasting
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Gastroesophageal Reflux Imaging
|
The procedure involves the administration of Tc99m Sulfur Colloid per orem and scanning of region of interest follows for 2 hours
|
To evaluate and determine the quantity of esophageal movement; To detect and determine the quantity of gastro-esophageal reflux; to diagnose any functional gastric obstruction
|
6 hours fasting
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Hepatobiliary Imaging
|
Procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To evaluate any sudden inflammation of the gallbladder, common bile duct obstruction, right upper quadrant pain or mass, detection of enterogastric reflux; to check for any leakage of bile and evaluate any choledochal cyst
|
2 hours fasting for pediatric and 4 hours fasting for adults
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
UBT Urea Breath Test
|
The procedure involves administration of radioactive capsule and blowing on a breathcard after 15-20 minutes
|
To check if the patient has H. Pylori infection
|
6 hours fasting
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Renal Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To evaluate renal masses, whether cyst, neoplasm or abcess and renovascular hypertension. To detect any complications of transplantation which includes parenchymal failure due to acute tubular necrosis, rejection, mechanical failure caused by injury to renal artery or vein, partial or complete ureteral obstruction and extravasation
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Renal Imaging with Captopril
|
Captopril is administered to the patient by mouth. Vital signs are monitored for 1 hour at 15-minute interval. It involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To check for renal hypertension
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Diuretic Renal Imaging
|
It involves injection of radiopharmaceutical tracer, scanning of the organ of interest and administration of diuretic halfway during the scanning
|
To check for any renal collecting system obstruction, to diagnose acute tubular necrosis, to evaluate renal trauma, perfusion and function
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Renal Imaging (EC)
|
It involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To check renal masses, whether cyst, neoplasm or abcess and renovascular hypertension. To detect complications of transplantation which includes parenchymal failure due to acute tubular necrosis, rejection, mechanical failure caused by injury to renal artery or vein, partial or complete ureteral obstruction and leakage
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Renal Imaging MAG 3
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To evaluate renal masses, whether cyst, neoplasm or abcess and renovascular hypertension. To detect complications of transplantation which includes parenchymal failure attributable to acute tubular necrosis, rejection, mechanical failure caused by injury to renal artery or vein, partial or complete ureteral obstruction and leakage
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
DMSA Renal Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To evaluate acute or chronic pyelonephritis
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Indirect Cystogram
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To evaluate vesicouteral reflux
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
GFR
|
It involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To evaluate any renal collecting system obstruction, to diagnose acute tubular necrosis and glomerular filtration rate
|
Hydration or continuous drinking of water to keep the body hydrated (except for patients with heart congestion)
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Testicular Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To examine acute and chronic testicular pain and scrotal swelling; differentiation of epididymitis from torsion
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Bone Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the skeletal system
|
To determine the stage of a malignant disease; follow-up of patient after treatment of a malignant disease; primary bone tumors, arthritis, osteomalacia; to check a specific area for biopsy
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Bone SPECT Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To study a specific area for any bone abnormality caused by trauma, infection, arthritis and tumor
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
3 Phase Bone Scan
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To differentiate osteomyelitis vs. cellulitis
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Lung Perfusion Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To check for any pulmonary disease like tumor, Pneumonia, emphysema and atelecatasis
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Lung Ventilation Imaging
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To check for pulmonary emobolism
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Venography
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To check for deep vein thrombosis in patients with contraindication to radiographic contrast
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Lung Quantitation
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To evaluate lung perfusion
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Blood Volume
|
It involves injection of pyrophosphate and Tc99m pertechnetate and extraction of blood for evaluation of blood volume
|
To check for polycuythemia vera
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Red Blood Cell (RBC) Survival
|
The procedure involves extraction and labeling of RBC with Chromium, reinjection of labeled RBC, serial extraction of blood and obtaining of counts of regions of interest using external detector to evaluate RBC survival
|
To evaluate RBC survival rate and examine patient with splenic sequestration, a condition that causes the spleen to fill with blood and become large and tender
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Splenic Sequestration
|
Procedure involves extraction and labeling of Red Blood Cells (RBC) with Chromium, reinjection of labeled RBC, serial extraction of blood and obtaining of counts of regions of interest using external detector for evaluation of RBC survival
|
To evaluate RBC survival rate and examine patient with splenic sequestration, a condition that causes the spleen to fill with blood and become large and tender
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Lymphangioscinti-
graphy
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To check for primary and secondary lymphedema
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
White Blood Leucocyte Labeling
|
The procedure involves extraction of blood, separation and labeling of White Blood Cells and reinjection of labeled WBC then scanning of the whole body
|
To check a specific area of sore and infection and evaluation of inflammation
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Ga-67 Whole body
|
The procedure involves injection of Gallium 67 citrate and scanning of the whole body
|
To determine the stage of Hidgkin's disease and lymphoma; to monitor the body’s response to antineoplastic therapy; to determine the specific site of primary lung tumor
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Cisternography
|
|
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Scintimammography
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To check for malignant breast infections or wounds in patients with unclear or suspicious mammography findings
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
Dacryoscintigraphy
|
The procedure involves injection of radiopharmaceutical tracer and scanning of the region of interest
|
To examine lacrimal duct obstruction
|
None
|
Hypersensitivity or allergic reactions to the radioisotope/ radiopharmaceutical
|
|
|
FT3 RIA
|
The procedure involves addition of I-125 tracer to a serum in a test tube, incubation and counting of the substance under analysis using a gamma counter
|
To determine free triiodothyroinine in the blood and make comparative diagnosis of thyroid disease
|
None
|
None
|
|
|
FT4 RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substance under analysis using a gamma counter
|
To determine free thyroxine in the blood and make comparative diagnosis of thyroid disease
|
None
|
None
|
|
|
TSH IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substance under analysis using a gamma counter
|
To identify thyroid stimulating hormone. Make comparative diagnosis of thyroid disease and response to therapy
|
None
|
None
|
|
|
Thyroglobulin IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substance under analysis using a gamma counter
|
Helps in identifying the presence or absence of functioning tissue
|
None
|
None
|
|
|
PTH IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substance under analysis using a gamma counter
|
To measure the PTH level in blood as an aid in the diagnosis of Hypercalcemia and hypocalcemia
|
Overnight fasting. Blood extraction at 1000H
|
None
|
|
|
Anti TPO RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substance under using a gamma counter
|
To check Thyroid Peroxidase Antibodies in the blood present in autoimmune Thyroiditis like hashimoto's Thyroiditis, postpartum Thyroiditis, and atrophic thyroiditis
|
No preparation required but if blood is lipemic, meaning there are fatty substances present in the blood, fasting is required from 12 midnight
|
None
|
|
|
Anti-hTg RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To check for Thyroglobulin Antibodies in blood present in various forms of autoimmune thyroid diseases like Basedow's disease, Hashimoto's Thyroiditis, and primary myxedema
|
No preparation required but if blood is lipemic, meaning there are fatty substances present in the blood, fasting is required from 12 midnight
|
None
|
|
|
CEA IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of tumor marker, Carcinoembryonic antigen, as an aid in the management of cancer patients
|
None
|
None
|
|
|
Digoxin RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
Helps in the monitoring of administration of cardioglycosides for therapy
|
No fasting required. Sample is taken 6 hours after lanoxin intake
|
None
|
|
|
Estradiol RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of Estradiol in blood as an aid in the comparative diagnosis of Ammenorrhea, monitoring of ovulation induction, precocious puberty in girls and gynecomastia in men.
|
None
|
None
|
|
|
FSH IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of Follicle Stimulating Hormone in blood for the diagnosis gonadal and pituitary disorders
|
None
|
None
|
|
|
LH IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of Luteinizing Hormone in blood and aids in the diagnosis of gonadal failure and deficient gonadal stimulation
|
None
|
None
|
|
|
Testosterone RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of Testosterone level in blood. To determine gonadal state
|
None
|
None
|
|
|
DHEA-S RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the DHEA-S level in blood/ Hirsutism and balding; Helps in assessing adrenarche and delayed puberty; to detect polycystic ovary and adrenal hyperplasia
|
None
|
None
|
|
|
b-HCG IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of Beta-HCG in blood; to confirm pregnancy, ectopic pregnancy, threatened spontaneous abortion and multiple gestation; to detect hydatidiform mole choriocarcinoma
|
None
|
None
|
|
|
Prolactin IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of Prolactin level for evaluation of amenorrhea and galactorrhea and detection of pituitary tumor
|
No fasting required. Sample is taken 3-4 hours after the patient woke up
|
None
|
|
|
Plasma Cortisol RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of cortisol level to diagnose Cushing's and Addison's disease, Hypopituitarism and adrenal hyperplasia and carcinoma
|
None
|
None
|
|
|
HGH IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the rate of Human Growth Hormone for detection of various forms of inappropriate growth hormone secretions in cases like dwarfism, gigantism, and acromegaly
|
Fasting
|
None
|
|
|
CA-125 IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of CA-125 to aid in patient management and diagnosis of ovarian cancer
|
None
|
None
|
|
|
Gastrin RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of Gastin level for detection of Zollinger-Ellison Syndrome and achlorhydria
|
Fasting
|
None
|
|
|
Renin RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of plasma Renin activity for the differential diagnosis of primary and secondary aldosternonism; helps in the diagnosis and treatment of renal hypertension
|
No fasting required. Blood is extracted according to physician's instruction whether the patient is in upright or supine position after lying or moving for 2-3 hours
|
None
|
|
|
Aldosterone RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of aldosterone level important in the diagnosis of primary and secondary hyperaldosteronism
|
No fasting required. Blood is extracted according to physician's instruction whether the patient is in upright or supine position after lying or moving for 2-3 hours
|
None
|
|
|
C-Peptide IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of C-peptide level; Helps in the differentiating of the course of hyperglycemia, i.e. insulin insufficiency or insulin resistance
|
Fasting
|
None
|
|
|
Anti-R TSH (TRAb) RRA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To measure the quantity of TSH Receptor Antibody to distinguish Grave's disease from toxic nodular goiter; in pregnancy where there is concern about the possibility of fetal and neonatal hyperthyroidism, in euthyroid exophthalmos in antithyroid therapy for Grave's disease in relation to the possibility of a remission or relapse; in Hypothyroidism where the possibility of a blocking antibody is present
|
None
|
None
|
|
|
ACTH IRMA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To determine the quantity of ACTH level to examine disorders of the adrenal and pituitary glands
|
Fasting
|
None
|
|
|
HBsAg RIA
|
Captopril is administered to the patient by mouth. Vital signs are monitored for 1 hour at 15-minute interval. Procedure involves injection of radiopharmaceutical tracer and scanning of the organ of interest
|
To detect Hepatitis B Surface Antigen in serum
|
None
|
None
|
|
|
Anti-HBs RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To identify Antibody to Hepatitis B Surface Antigen in serum
|
None
|
None
|
|
|
Anti-HBc M RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To detect IgM Hepatitis B Core Antibody in serum
|
None
|
None
|
|
|
Anti-HAV M RIA
|
The procedure involves addition of I-125 tracer to a volume of serum in a test tube, incubation and counting of substances under analysis using a gamma counter
|
To detect IgM Hepatitis A Antibody
|
None
|
None
|
|
